These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 15714119

  • 1. VEGF and VEGFR-2 immunohistochemistry in human melanocytic naevi and cutaneous melanomas.
    Pisacane AM, Risio M.
    Melanoma Res; 2005 Feb; 15(1):39-43. PubMed ID: 15714119
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions.
    Simonetti O, Lucarini G, Brancorsini D, Nita P, Bernardini ML, Biagini G, Offidani A.
    Cancer; 2002 Nov 01; 95(9):1963-70. PubMed ID: 12404291
    [Abstract] [Full Text] [Related]

  • 3. The role of vascular endothelial growth factors and their receptors in malignant melanomas.
    Brychtova S, Bezdekova M, Brychta T, Tichy M.
    Neoplasma; 2008 Nov 01; 55(4):273-9. PubMed ID: 18505336
    [Abstract] [Full Text] [Related]

  • 4. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
    Massi D, Franchi A, Sardi I, Magnelli L, Paglierani M, Borgognoni L, Maria Reali U, Santucci M.
    J Pathol; 2001 Jun 01; 194(2):194-200. PubMed ID: 11400148
    [Abstract] [Full Text] [Related]

  • 5. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas.
    Fröhlich E, Mack AF, Garbe C, Klessen C.
    Br J Dermatol; 2005 Dec 01; 153(6):1159-65. PubMed ID: 16307652
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cadherin expression in melanocytic naevi and malignant melanomas.
    Cowley GP, Smith ME.
    J Pathol; 1996 Jun 01; 179(2):183-7. PubMed ID: 8758211
    [Abstract] [Full Text] [Related]

  • 8. Association of vascular endothelial growth factor expression with patohistological parameters of cutaneous melanoma.
    Gacević M, Jović M, Zolotarevski L, Stanojević I, Novaković M, Miller K, Šuljagić V, Mijušković Ž, Vojvodić D.
    Vojnosanit Pregl; 2016 May 01; 73(5):449-57. PubMed ID: 27430109
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CD31 and CD34 expression as immunohistochemical markers of endothelial transdifferentiation in human cutaneous melanoma.
    Pisacane AM, Picciotto F, Risio M.
    Cell Oncol; 2007 May 01; 29(1):59-66. PubMed ID: 17429142
    [Abstract] [Full Text] [Related]

  • 11. Macrophage migration inhibitory factor protein and mRNA expression in cutaneous melanocytic tumours.
    Miracco C, De Nisi MC, Arcuri F, Cosci E, Pacenti L, Toscano M, Lalinga AV, Biagioli M, Rubegni P, Vatti R, Maellaro E, Del Bello B, Massi D, Luzi P, Tosi P.
    Int J Oncol; 2006 Feb 01; 28(2):345-52. PubMed ID: 16391788
    [Abstract] [Full Text] [Related]

  • 12. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in human malignant melanoma and their relation to angiogenesis.
    Tu YT, Tao J, Liu YQ, Li Y, Huang CZ, Zhang XB, Lin Y.
    Clin Exp Dermatol; 2006 May 01; 31(3):413-8. PubMed ID: 16681591
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Moesin and CD44 expression in cutaneous melanocytic tumours.
    Ichikawa T, Masumoto J, Kaneko M, Saida T, Sagara J, Taniguchi S.
    Br J Dermatol; 1998 May 01; 138(5):763-8. PubMed ID: 9666819
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hypoxia-inducible factors 1alpha and 2alpha are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin.
    Giatromanolaki A, Sivridis E, Kouskoukis C, Gatter KC, Harris AL, Koukourakis MI.
    Melanoma Res; 2003 Oct 01; 13(5):493-501. PubMed ID: 14512791
    [Abstract] [Full Text] [Related]

  • 19. E-cadherin/catenin complex in benign and malignant melanocytic lesions.
    Silye R, Karayiannakis AJ, Syrigos KN, Poole S, van Noorden S, Batchelor W, Regele H, Sega W, Boesmueller H, Krausz T, Pignatelli M.
    J Pathol; 1998 Dec 01; 186(4):350-5. PubMed ID: 10209482
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.